Close

Needham & Company Reinstates Coverage on Hologic (HOLX) at Buy; The 3-D Upgrade Cycle is Just Around the Corner Dec 5, 2011 08:02AM
Needham & Company Reiterates a 'Buy' Rating on Hologic (HOLX); FDA Panel Votes In Favor Of 3D Mammography Sep 27, 2010 08:38AM
Needham & Company Reiterates a 'Buy' Rating on Hologic (HOLX); FDA Panel on Sept 24 Potential Catalyst Aug 3, 2010 07:52AM
Notable Analyst Rating Changes 06/03: HOLX, SCHW, KEY, EBAY Upgraded; DIVX, BP, CWTR, ACAS Downgraded Jun 3, 2010 10:50AM
Needham & Company Upgrades Hologic (HOLX) to Buy; Survey Data Supports Emerging Upgrade Cycle for Digital Mammography Jun 3, 2010 07:34AM


May 4, 2010 08:35AM Needham & Company Reiterates a 'Hold' on Hologic (HOLX); F2Q10 Topline Beat, Guidance Below Expectations
Aug 4, 2009 10:26AM Notable Analyst Rating Changes 8/4: HBC, HGSI, PKY, DISH, TLB Upgraded; HOLX, ATML, ABX, STEC, LAMR Downgraded
Apr 14, 2009 09:58AM Notable Analyst Rating Changes 4/14: BRCD, ALB, DPS, OMI, PL Upgraded; SNDA, BYD, STX, ESI Downgraded
Jan 9, 2009 11:21AM Needham Downgrades Hologic (HOLX) to Hold
Feb 14, 2008 10:19AM Notable Analyst Rating Changes 2/14: BIDU, VCLK, CHK Upgraded; LVLT, NHWK, IM Downgraded